References

Sex and Gender in Biomedical Research : References

Lesson 1

1. Garnett, C. (2002). Beyond the bikini view: Scientists urged to expand gender specific research portfolios. NIH Record, LIV, 25. Retrieved February 3, 2006, from National Institutes of Health Web site: http://nihrecord.od.nih.gov/newsletters/12_10_2002/story01.htm.
2. U.S. Department of Health and Human Services. Food and Drug Administration. Investigational New Drug Applications and New Drug Applications, 21 C.F.R. Parts 312 and 414 (1998). Federal Register. February 11, 1998 (Volume 63, Number 28), Rules and Regulations, pp. 6854-6862. Retrieved February 3, 2006, from Food and Drug Administration Web site: http://www.fda.gov/oashi/patrep/demo.html.
3. Fishman, J. R., Wick, J. G., & Koenig, B. A. (1999). The use of "sex" and "gender" to define and characterize meaningful differences between men and women. In Agenda for research on women's health for the 21st century: A report of the task force on the NIH women's health research agenda for the 21st century, volume 2, pp.15-20. Retrieved February 3, 2006, from Office of Research on Women's Health Web site: http://orwh.od.nih.gov/pubs/agenda_book_2.pdf
4. Institute of Medicine, Committee on Understanding the Biology of Sex and Gender Differences. (2001). Exploring the biological contributions to human health: Does sex matter? (T. M. Wizemann & M. L. Pardue, Eds.). Washington, DC: National Academy Press.
5. World Health Organization. The Department of Gender and Women's Health (GHW). Retrieved February 3, 2006 from: http://www.who.int/gender/en/
6. Nicolette, J. (2000). Searching for women's health: a resident's perspective. Journal of Women's Health & Gender-Based Medicine, 9, 697-701.
7. U.S. Department of Health and Human Services. Basic HHS Policy for Protection of Human Subjects, 45 C.F.R. Part 46 Subpart A (2004). Retrieved February 3, 2006, from DHHS Office for Human Research Protections Web site: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm
8. Institute of Medicine. Exploring the biological contributions to human health (2001), p. 25.
9. Merkatz, R. B., & Junod, S. W. (1994). Historical background of changes in FDA policy on the study and evaluation of drugs in women. Academic Medicine, 69, 703-707. PubMed
10. U.S. Department of Health and Human Services. Food and Drug Administration. Investigational New Drug Applications and New Drug Applications. (1998)
11. U.S. Department of Health and Human Services. National Institutes of Health. National Institutes of Health Revitalization Act of 1993. Subtitle B: Clinical Research Equity Regarding Women and Minorities. (1993). Retrieved February 3, 2006, from Office of Research on Women's Health Web site: http://orwh.od.nih.gov/inclusion/revitalization.pdf.
12. U.S. Department of Health and Human Services. National Institutes of Health. (2001). NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research- Amended October 2001. Retrieved February 3, 2006, from NIH Office of Extramural Research Web site: http://grants1.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
13. U.S. General Accounting Office. (2000). Women's health: NIH has increased its efforts to include women in research (Publication No. GAO/HEHS-00-96). Retrieved February 3, 2006, from U.S. General Accounting Office Web site: http://www.gao.gov/archive/2000/he00096.pdf.

PDF files require the free Adobe Acrobat Reader

The following page includes a quiz that will be used to assess your mastery of the lesson content. If you are completing the course for continuing medical education, you must successfully complete each lesson quiz to receive credit.